EcoNugenics® Wins the 2004 Nutrition Business Journal Product Merit Award for PectaSol® Modified Citrus Pectin

Good news in the nutraceutical industry. EcoNugenics received the 2004 Nutrition Business Journal Product Merit Award for PectaSol® MCP. Studies have demonstrated its impact on inhibiting cancer metastasis and reducing tumor growth. It has been particularly effective in the treatment of prostate cancer. PectaSol® is more readily absorbed into the bloodstream than other pectin due to its structure and molecular weight.

Santa Rosa, CA (PRWEB) March 10, 2005 -- EcoNugenics,® a premium dietary supplement and nutraceutical company, announced today that they have received the 2004 Nutrition Business Journal Product Merit Award for PectaSol,® Modified Citrus Pectin, a dietary supplement derived from the peel and pulp of citrus fruit. The dietary supplement is recognized for its interaction with cellular adhesion.

“EcoNugenics® is honored to receive this Product Merit Award from The Nutrition Business Journal,” said Isaac Eliaz, MD, a leader in the field of Integrative Medicine. “The strategic information about PectaSol® is that studies have demonstrated its effect on inhibiting cancer metastasis and reducing tumor growth. In prostate cancer, PectaSol® has been clinically shown to considerably slow the prostate specific antigen, PSA doubling time.”

The molecular weight and proper structure of the citrus pectin used in PectaSol® have been modified through several proprietary laboratory processes, making PectaSol® more readily absorbed into the bloodstream than regular pectin. PectaSol’s unique component, galactyosyl, has an affinity for binding to certain cells of the prostate, breast, colon, lymphatic system, skin, brain and larynx. For more information and to view clinical research on PectaSol® visit www.econugenics.com.

EcoNugenics® was founded in 1995 with a commitment to offering premium dietary supplements and nutraceuticals based on the best of modern science integrated with the ancient wisdom of traditional and complementary therapies. EcoNugenics® is committed to five basic principles, which include innovation in product formulation, thorough scientific research, ongoing clinical validation, customer education/empowerment and superior quality control.

For more information contact Connie St. John at 415-454-2243.

# # #

Source :  http://www.prweb.com/releases/2005/3/prweb216416.htm